Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

C.M. Fehres, H. Kalay, S.C.M. Bruijns, S.A.M. Musaafir, M. Ambrosini, L. van Bloois, S.J. van Vliet, G. Storm, J.J. Garcia Vallejo, Y. van Kooyk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)67-76
JournalJournal of Controlled Release
Volume203
DOIs
Publication statusPublished - 2015

Cite this

@article{62e24e2e1e584184ba18f4103d04214a,
title = "Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens",
author = "C.M. Fehres and H. Kalay and S.C.M. Bruijns and S.A.M. Musaafir and M. Ambrosini and {van Bloois}, L. and {van Vliet}, S.J. and G. Storm and {Garcia Vallejo}, J.J. and {van Kooyk}, Y.",
year = "2015",
doi = "10.1016/j.jconrel.2015.01.040",
language = "Undefined/Unknown",
volume = "203",
pages = "67--76",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens. / Fehres, C.M.; Kalay, H.; Bruijns, S.C.M.; Musaafir, S.A.M.; Ambrosini, M.; van Bloois, L.; van Vliet, S.J.; Storm, G.; Garcia Vallejo, J.J.; van Kooyk, Y.

In: Journal of Controlled Release, Vol. 203, 2015, p. 67-76.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

AU - Fehres, C.M.

AU - Kalay, H.

AU - Bruijns, S.C.M.

AU - Musaafir, S.A.M.

AU - Ambrosini, M.

AU - van Bloois, L.

AU - van Vliet, S.J.

AU - Storm, G.

AU - Garcia Vallejo, J.J.

AU - van Kooyk, Y.

PY - 2015

Y1 - 2015

U2 - 10.1016/j.jconrel.2015.01.040

DO - 10.1016/j.jconrel.2015.01.040

M3 - Article

VL - 203

SP - 67

EP - 76

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -